An antidepressant
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Metapramine

Item No. 42033

Technical Information
Formal Name
10,11-dihydro-N,5-dimethyl-5H-dibenz[b,f]azepin-10-amine
CAS Number
21730-16-5
Synonyms
  • RP 19560
Molecular Formula
C16H18N2
Formula Weight
Purity
≥98%
A solution in ethanol
Ethanol: Soluble: ≥10 mg/ml
SMILES
CN1C2=C(C=CC=C2)C(NC)CC3=C1C=CC=C3
InChi Code
InChI=1S/C16H18N2/c1-17-14-11-12-7-3-5-9-15(12)18(2)16-10-6-4-8-13(14)16/h3-10,14,17H,11H2,1-2H3
InChi Key
YXVZOBVWVRFPTE-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Metapramine is an antidepressant.1 It decreases action potential amplitude and maximal signal velocity and increases conduction time in isolated dog Purkinje fibers when used at a concentration of 10 µM. Metapramine (10 mg/kg) reduces ethanol consumption in ethanol-preferring rats.2 It inhibits reperfusion-induced increases in ventricular arrhythmias in a rat model of myocardial ischemia-reperfusion injury induced by ligation of the left anterior descending (LAD) artery when used at a concentration of 175 µM.3 Metapramine (10 mg/kg) increases the latency to tail withdrawal in the tail-flick test and inhibits phenylbenzoquinone-induced writhing in mice when administered at a dose of 10 mg/kg.4 Formulations containing metapramine have been used in the treatment of depression.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Bril, A., Rochette, L., Bertrand, J.P., et alElectrophysiological effects of some antidepressant drugs on canine cardiac Purkinje fibres. Cardiovasc. Res. 21(11), 783-789 (1987).

    2. Daoust, M., Saligaut, C., Chadelaud, M., et alAttenuation by antidepressant drugs of alcohol intake in rats. Alcohol 1(5), 379-383 (1984).

    3. Bril, A., and Rochette, L. Comparison of the effect of antidepressant drugs on arrhythmias in the isolated rat heart subjected to myocardial ischaemia and reperfusion. Pharmacol. Toxicol. 60(4), 249-254 (1987).

    4. Michael-Titus, A., and Costentin, J. Analgesic effects of metapramine and evidence against the involvement of endogenous enkephalins in the analgesia induced by tricyclic antidepressants. Pain 31(3), 391-400 (1987).